益盛药业
(002566)
| 流通市值：16.62亿 | | | 总市值：23.73亿 |
| 流通股本：2.32亿 | | | 总股本：3.31亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 110,345,172.16 | 71,479,841.19 | 108,908,752.89 | 118,163,587.06 |
| 应收票据及应收账款 | 157,039,835.88 | 150,627,454.1 | 165,977,067.19 | 149,280,245.85 |
| 其中：应收票据 | 884,826.2 | 1,092,066.42 | 776,653.5 | 791,542.53 |
| 应收账款 | 156,155,009.68 | 149,535,387.68 | 165,200,413.69 | 148,488,703.32 |
| 应收款项融资 | 48,404,312.18 | 48,402,514.61 | 37,656,730.3 | 35,906,365.46 |
| 预付款项 | 5,585,608.87 | 1,578,217.09 | 10,706,017.72 | 5,558,951.16 |
| 其他应收款合计 | 19,133,680.22 | 15,046,882.82 | 14,225,841.7 | 15,255,425.9 |
| 存货 | 1,615,542,471.37 | 1,626,488,729.46 | 1,626,091,073.04 | 1,633,039,799.53 |
| 其他流动资产 | 2,262,131.59 | 2,484,964.33 | 4,612,400.28 | 2,809,489.86 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,426,571,304.74 | 2,375,780,311.63 | 2,401,423,352.02 | 2,392,584,958.4 |
| 非流动资产: | | | | |
| 固定资产 | 429,972,955.74 | 437,935,245.15 | 447,201,988.68 | 456,545,057 |
| 使用权资产 | 11,318,688.19 | 12,401,656.85 | 9,714,502.78 | 10,632,202.05 |
| 无形资产 | 110,689,706.95 | 111,348,014.44 | 112,059,228.85 | 112,767,012.25 |
| 商誉 | 1,905,827.33 | 1,905,827.33 | 1,905,827.33 | 1,905,827.33 |
| 长期待摊费用 | 1,863,286.99 | 2,153,090.27 | 2,150,137.82 | 2,124,717.88 |
| 递延所得税资产 | 13,159,642.67 | 13,147,314.12 | 13,399,330.3 | 12,507,591.46 |
| 其他非流动资产 | 16,945,327.12 | 15,982,925.83 | 17,013,363.37 | 15,658,491.67 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 585,855,434.99 | 594,874,073.99 | 603,444,379.13 | 612,140,899.64 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,012,426,739.73 | 2,970,654,385.62 | 3,004,867,731.15 | 3,004,725,858.04 |
| 流动负债: | | | | |
| 短期借款 | 345,018,874.14 | 290,283,555.56 | 320,365,430.57 | 320,266,477.79 |
| 应付票据及应付账款 | 13,598,996.38 | 13,001,831.67 | 14,472,839.86 | 20,364,824.12 |
| 应付账款 | 13,598,996.38 | 13,001,831.67 | 14,472,839.86 | 20,364,824.12 |
| 合同负债 | 5,384,929.13 | 5,492,542.94 | 14,506,389.15 | 9,813,818.19 |
| 应付职工薪酬 | 7,991,762.62 | 6,846,279.33 | 9,502,170.16 | 9,291,154.98 |
| 应交税费 | 9,609,169.97 | 8,559,848.74 | 10,677,605.08 | 10,530,248.68 |
| 其他应付款合计 | 28,575,229.87 | 37,722,466.23 | 44,206,375.03 | 41,345,878.36 |
| 一年内到期的非流动负债 | 3,816,896.7 | 3,398,981.11 | 3,001,487.39 | 2,890,570.01 |
| 其他流动负债 | 676,040.33 | 696,712.19 | 1,831,942.3 | 1,106,421.48 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 414,671,899.14 | 366,002,217.77 | 418,564,239.54 | 415,609,393.61 |
| 非流动负债: | | | | |
| 长期借款 | 134,700,000 | 149,700,000 | 150,000,000 | 150,000,000 |
| 租赁负债 | 3,617,567.46 | 6,205,673.58 | 3,765,942.24 | 4,171,238.53 |
| 递延收益 | 111,381,726.59 | 112,541,655.91 | 114,907,837.32 | 117,251,188.51 |
| 递延所得税负债 | 2,584,514.52 | 2,770,442.76 | 1,449,274.74 | 1,554,321.86 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 252,283,808.57 | 271,217,772.25 | 270,123,054.3 | 272,976,748.9 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 666,955,707.71 | 637,219,990.02 | 688,687,293.84 | 688,586,142.51 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 330,951,600 | 330,951,600 | 330,951,600 | 330,951,600 |
| 资本公积 | 834,689,338.39 | 834,689,338.39 | 834,689,338.39 | 834,689,338.39 |
| 盈余公积 | 145,392,996.97 | 145,392,996.97 | 140,215,063.74 | 140,215,063.74 |
| 未分配利润 | 936,434,288.86 | 924,572,718.84 | 913,529,372.27 | 911,000,401.58 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,247,468,224.22 | 2,235,606,654.2 | 2,219,385,374.4 | 2,216,856,403.71 |
| 少数股东权益 | 98,002,807.8 | 97,827,741.4 | 96,795,062.91 | 99,283,311.82 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,345,471,032.02 | 2,333,434,395.6 | 2,316,180,437.31 | 2,316,139,715.53 |
| 负债和股东权益合计 | 3,012,426,739.73 | 2,970,654,385.62 | 3,004,867,731.15 | 3,004,725,858.04 |
| 公告日期 | 2025-04-24 | 2025-04-18 | 2024-10-26 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |